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Sugar, or technically known as glucose, is the main source of energy of all cells 
in the human body. The glucose homeostasis cycle is the mechanism to maintain 
blood glucose levels in a healthy threshold. When this natural mechanism is broken, 
many metabolic disorders appear such as diabetes mellitus, and some substances of 
interest, like glucose, are out of control. In the mechanism to maintain blood glucose, 
several organs are involved but the role of most of them has been disregarded in the 
literature. In this chapter, the main organs involved in such a mechanism and their 
role in glucose metabolism are described. Specifically, the stomach and small intes-
tine, organs of the gastrointestinal system, are the first to play an important role in 
the regulatory system, because it is where carbohydrates are digested and absorbed 
as glucose into the bloodstream. Then glucose as a simple substance goes to the liver 
to be stored as glycogen. Glucose storage occurs due to the delivery of hormones 
from the pancreas, which produces, stores, and releases insulin and glucagon, two 
antagonistic hormones with an important role in glucose metabolism. The kidneys 
assist the liver in insulin clearance in the postprandial state and gluconeogenesis in 
the post absorptive state. Physiological aspects and the detailed role of every organ 
involved in glucose metabolism are described in this chapter.
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1. Introduction
Glucose is contained in foods rich in carbohydrates like bread, potatoes, rice, 
and fruits. It can be as a simple molecule, sugar, or complex molecules, carbohy-
drates. Although carbohydrates are more abundant in the diet, they are digested 
to be converted into glucose molecules to be absorbed in the gut. Previously to be 
absorbed, stomach and small intestine play an important role in digestion every 
particle ingested. First, food reaches the stomach after being chewed and swallowed 
from mouth. The digestion of carbohydrates begins in the mouth with saliva while 
chewing, but continues in the small intestine because the acidic pH of the stomach 
inactivates the amylase enzyme that is responsible for breaking them down. In the 
small intestine, the digestion of carbohydrates ends to be absorbed, through the 
enterocytes, into the blood. Once the glucose molecules are absorbed into the blood-
stream, they reach the liver by traveling through the portal system. In the liver, they 
are partially stored as glycogen by the action of the insulin previously released in 
the pancreas. The rest of the glucose continues in the circulation, reaches the heart 
and all tissues and organs. Insulin concentrations are proportional to glucose con-
centrations due to this hormone make enter the glucose into the cells. In fact, insulin 
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concentrations released by the pancreas are usually higher than glucose concentra-
tions in blood. In this sense, the kidneys regulate glucose and insulin concentrations 
once these molecules reach them. Insulin is clearance in both, liver and kidneys, 
while glucose is produced from non-carbohydrates precursors in the postprandial 
state to compensate for the insulin excess in the blood. On the other hand, during a 
fasting period or a post-absorptive state, glucagon is released into the bloodstream 
by the pancreas and achieves the liver to dephosphorylate the glycogen into glucose 
to keep blood glucose levels in the healthy threshold. As can be seen from every-
thing mentioned above, blood glucose levels can be set at the desired threshold 
thanks to the joint work between all the organs of the human body, where they all 
play an important role in this regulatory system. Next sections.
2. Importance of glucose in the human body
Cells of the tissues in the human body use glucose, the simplest of the car-
bohydrates, as the main source of energy to carry out their metabolic processes. 
Despite this, glucose consumption should be moderate because an excess can trigger 
multiple metabolic disorders that can even be chronic. Carbohydrates start to be 
processed immediately they are ingested, i.e., its digestion begins in the mouth with 
the amylase in the saliva. Then, ingested food travels throughout the esophagus to 
the stomach. In the stomach, the enzyme amylase is inactivated due to acidic pH, 
so carbohydrates cannot continue to digest. Other nutrients such as protein and fat 
are partially digested in the stomach, about 5% and 20%, respectively [1]. Once the 
ingested food has the appropriate rheological properties, it passes through the pylo-
rus to reach the duodenum, the first part of the small intestine. In the duodenum, 
the bile produced from and gallbladder, is released to digest fats. The digestion of all 
nutrients ends in the small intestine by an additional intervention of the pancreas 
with the release of both pancreatic enzymes such as amylases, lipases, and prote-
ases, and hormones such as insulin and glucagon. The molecules produced during 
digestion are absorbed by the enterocytes into the bloodstream. The rest of the food 
that is not absorbed in the small intestine passes into the colon.
Once glucose is in the systemic circulation, insulin hormone helps it to enter into 
the cells. Inside the cells, glucose is broken down to produce adenosine triphosphate 
(ATP) molecules by means of glycolysis. ATP are energy-rich molecules that power 
numerous cellular processes. Therefore, a constant supply of glucose from the blood 
to the cells must be ensured. Negative feedback systems [2] are responsible to ensure 
blood glucose concentrations in a normal range of 70 to 110 milligrams of glucose 
per deciliter of blood ( /mg dL ) [3]. Negative feedback systems are mechanisms 
that perceive changes in the human body and activate mechanisms that reverse the 
changes to restore conditions to their normal levels. Furthermore, negative feed-
back systems are critically important in glucose homeostasis in the maintenance of 
relatively constant internal conditions. In this regard, negative feedback systems 
make the pancreas to produce and release more insulin when there is an excess 
glucose consumption. This fact, maintained over time, can cause disruptions in 
glucose homeostasis lead to potentially life-threatening such as insulin resistance 
and diabetes mellitus.
The body also use other sources of energy such as amino acids (building blocks 
of proteins) and fats. However, despite these alternative energy sources, a minimum 
level of glucose in the blood must be ensured mainly for the metabolic activities of the 
brain and nervous system. Glucose is the main source of fuel for the brain and nervous 
system. Nerve cells and chemical messengers need glucose to process information. On 
the other hand, the liver and muscles can store the leftover glucose in little bundles 
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called glycogen once the human body has used all the energy it needs. Glycogen works 
as a reserve fuel to be used during post-absorptive or fasting periods. Glycogenolysis 
is the biochemical process for converting glycogen to glucose in the liver. This process, 
together with the absorption of glucose in the small intestine after an ingested meal 
and the hepatic and renal gluconeogenesis, are the main factors to increase the levels 
of glucose in the blood. Sometimes, glucose levels in the blood can also go sky high 
under stressful conditions. Also, the High-Intensity Interval Training (HIIT) type of 
exercise is acknowledged to trigger (not completely understood) mechanisms able to 
rise the blood glucose levels. Contrary, the transport of the glucose into the cells by 
insulin action, physical exercise, and sometimes glycosuria (a condition characterized 
by an excess of sugar in the urine occurring under abnormal events when glucose 
homeostasis is impaired) are the main factors able to decrease blood glucose levels.
Regardless of the condition, the human body is designed to keep the level of glu-
cose in the bloodstream in healthy levels. However, when the glucose homeostasis is 
broken, diseases such as diabetes mellitus appear and persistent high blood glucose 
can lead generating acute complications such as diabetic ketoacidosis, retinopathy, 
diabetic nephropathy, neuropathy, and cardio-cerebrovascular disease. How does 
the body for regulating glucose levels in the blood? The next section introduces the 
glucose regulation cycle in detail and the role of every organ that is involved.
3. The glucose regulation cycle
Glucose homeostasis is the mechanism able to maintain the blood glucose levels 
near the range of 70 /mg dl  to 110 /mg dL  by the action of a complex interplay 
among organs, hormones, metabolic-systems, and neural control mechanisms. As 
mentioned above, glucose is the main source of energy by allowing essential cellular 
processes such as respiration, tissue repair, cell multiplication, to be carried out, 
among others. Production and release of pancreatic hormones, mainly insulin and 
glucagon, ensures the glucose regulation in the blood [3]. Figure 1 shows how the 
human body maintains glucose levels in a specific physiological range. Once carbo-
hydrates nutrients are ingested and enter the digestive tube, several enzymes begin 
to work to digest macronutrients, e.g., amylases trigger for polysaccharide break-
down. In this way, polysaccharides are converted into monosaccharides, 
smaller molecules able to be absorbed by enterocytes in the small intestine. 
Monosaccharides absorption leads to increased blood glucose levels in the blood-
stream. Simultaneously to this process, the incretin effect also occurs in which 
β-cells in the pancreas are stimulated by the action of GIP and GLP-1 hormones. 
Stimulation of β-cells drives the production and release of insulin, which increases 
the amount of GLUT4 glucose transporters in the cell membranes of different 
tissues [3]. Blood glucose concentrations also stimulate insulin production, and the 
hormones GIP and GLP-1 modulate it. As mentioned before, there are specialized 
molecules called GLUT to transport glucose from the blood into cells through cell 
membranes by diffusion. In this way, Excess glucose is eliminated from the 
blood, decreasing it. This process is represented in the figure with the plus sign. 
Therefore, glucose is transported within muscle and adipocytes cells, hepatocytes, 
neurons, etc., to be used as a source of energy. The liver is also answerable to sense 
blood glucose concentrations coming from the portal system and systemic circula-
tion. In the liver, enzymes known as glucokinase are responsible to sense glucose 
amount, stimulate its diffusion through the hepatocytes, and simultaneously 
produce glycogen from glucose excess. Glycogen is a multibranched polysaccharide 
of glucose used as glucose storage to be used during fasting periods as an energy 
source in the cells [4].
Sugar Intake - Risks and Benefits and the Global Diabetes Epidemic
4
During fasting periods, glucose levels in the blood decrease causing inhibi-
tion of insulin production in the pancreas by the action of hormones known as 
catecholamines [4]. Consequently, α-cells in the pancreas are stimulated to produce 
glucagon hormone that acts antagonistically to insulin. Glucagon makes a function 
on the different hepatocyte receptors triggering both the action of the phosphory-
lase enzyme and the glycogenolysis process. Glycogenolysis is the process in which 
glycogen is converted into glucose to increase blood glucose levels and recover the 
lack of glucose, setting its concentrations in the desired levels [5]. This is symbol-
ized in Figure 1 by the minus sign.
Diabetes Mellitus is a condition appearing when the glucose homeostasis is bro-
ken, that is, plasma glucose levels are no longer maintained at desired levels. This 
is mainly due to a deficit in the production of insulin from the pancreatic β-cells or 
from a resistance to the action of the produced insulin.
4. Main organs involved in glucose homeostasis
Although some organs need fatty acids to carry out their metabolic processes, 
most tissues in the human body use glucose as their main source of energy. Good 
glucose utilization depends on keeping blood glucose levels within range at all times 
and on the proper functioning of the glucose homeostatic mechanism. Several 
complementary physiological processes are involved in the glucose homeostatic 
mechanism. The gastrointestinal tract is responsible to produce and absorb glucose, 
the liver carries out biochemical reactions such as glycogenolysis, glycolysis, and 
gluconeogenesis, the kidneys filter, reabsorb, and in some cases excrete glucose, 
Figure 1. 
The glucose homeostasis in the human body.
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and they also produce glucose from non-carbohydrate precursors. The role of the 
main organs involved in the glucose regulation cycle is described below.
4.1 Pancreas
The pancreas is a special organ because has both endocrine and exocrine 
functions. Exocrine functions consist of the production and secretion of digestive 
enzymes whereas endocrine functions include production and secretion of hor-
mones. This chapter is primarily focused in the endocrine function given the 
crucial role on glucose homeostasis. Endocrine component of the pancreas consists 
of clustered cells forming the so-called islets of Langerhans. Islets of Langerhans 
are small island-shaped structures within exocrine pancreatic tissue representing 
only 1–2% of the entire organ [6]. The pancreatic islet endocrine cells include five 
different types that produce and release important hormones directly into the 
bloodstream: α  -cells produce glucagon, β -cells produce amylin-, C-peptide, and 
insulin [7], γ -cells produce pancreatic polypeptide (PP) [8], δ -cells produce 
somatostatin [7], and ε -cells produce ghrelin [9]. Two of the pancreatic hormones 
play an essential role in the regulation of the blood glucose levels are insulin, which 
acts to lower it, and glucagon, which acts to raise it [10]. The balanced antagonistic 
action between them, maintain the glucose concentrations within the narrow range 
of 4–6 mM  (70 to 110 /mg dL ) [6]. However, both hormones are inhibited by 
somatostatin [11]. Production and secretion of the hormones by pancreatic cells are 
stimulated by external signals such as nutrients intake, fasting, or stress. Blood 
glucose levels decrease during periods of rest such as sleep, between meals, or 
during fasting periods. In these cases, pancreatic α -cells release glucagon to drive 
glycogenolysis and gluconeogenesis processes. Unlike, in postprandial state, i.e., 
after a meal ingestion, insulin is released from β -cells in the pancreas to reduce 
blood glucose levels via glycogenesis [12–14]. Insulin is released on demand but is 
produced and stored in large, dense-core vesicles that are recruited near the plasma 
membrane into the β -cells in the islets of Langerhans after stimulation so that 
insulin is readily available to upcoming stimuli [15]. Glucose is the main signal to 
release insulin from the pancreas, but free fatty acids and amino acids can increase 
glucose-induced insulin secretion through the so-called incretin effect. As before 
mentioned, the incretin effect is originated in the intestinal tract (mainly duode-
num) once the food is ingested.
Insulin is a protein made up of 51 amino acids and when produced, it is first syn-
thesized as a single polypeptide known as preproinsulin. Preproinsulin is an insulin 
gene encoded in 110 amino acids that are then processed into proinsulin. Proinsulin 
undergoes maturation into active insulin through the action of two different types 
of cells. One of them cleaves at 2 positions, releasing insulin and a fragment known 
as C-peptide [16], in an equimolar ratio, into the bloodstream.
Insulin is released from β-cells in the pancreas in two phases, first one is triggered 
in response to glucose levels and second one is triggered independently of sugar. 
Glucose and insulin in the bloodstream work together to avoid glucose from going 
out of range. Thus, Glucose is removed from the circulation thanks to the ability of 
insulin to cause insulin-dependent tissues to take up glucose [17–19]. Additionally, 
insulin promotes lipogenesis [20, 21], and the incorporation of amino acids into pro-
teins [22] when it is in high concentrations. Different at low concentrations, which 
produce lipolysis in adipocytes, releasing free fatty acids by stimulating the use of 
lipids over glucose to satisfy energy needs at rest [23]. The release of insulin from 
β-cells is tightly regulated and exactly satisfies the metabolic demand for caloric 
nutrients in the body [16, 23]. Regarding C-peptide, it has been important to follow 
some insulin states that are difficult to measure [24].
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4.2 Liver
The liver is perhaps considered the main blood glucose regulating organ in the 
human body because it functions in two different ways: controlling the rate of 
glucose absorption from the portal system and producing glucose from non-carbo-
hydrate precursors or glycogen. As a curious fact, the liver is the only organ being 
irrigated by venous and arterial blood simultaneously. Venous irrigation comes 
from the portal system, provides the 75% of the blood supply, and carries blood 
rich in nutrients that were absorbed from the small intestine through enterocytes 
and hormones that were released by the pancreas. On the other hand, 25% of the 
remaining hepatic blood supply is arterial supply and is oxygen-rich blood coming 
from the aorta [4]. Blood from terminal branches of the hepatic artery and portal 
vein at the periphery of lobules is emptied into low-pressure vascular channels 
called sinusoids. Sinusoids are lined with endothelial cells and flanked circumferen-
tially by plates of parenchymal cells-hepatocytes allowing the exchange of nutrients 
and oxygen between the blood and the hepatic cells [25]. Millions of sinusoids made 
up the lobules in the liver. Hepatocytes take up nutrients from blood in the sinusoid 
and once carry on all metabolic functions, return the substances resulting from the 
biochemical reactions to the blood via hepatic vein.
As mentioned earlier, the liver is a key organ in maintaining glucose concentra-
tions in the desired range over both post-absorptive and postprandial states1. In 
the liver, four biochemical processes regarding glucose metabolism take place: 
glucose production from glycogen (glycogenolysis) and from non-carbohydrate 
precursors (gluconeogenesis), glucose consumption during the postprandial state 
(glucolysis), and glucose storage from the formation of glycogen (glycogenesis). 
Glucose phosphorylation (formation of glycogen) and dephosphorylation (forma-
tion of glucose from glycogen) occurs through the action of insulin and glucagon, 
respectively. Hepatocytes express dozens of enzymes that alternately turn on and 
off depending on whether blood glucose levels are rising or falling outside the 
normal range [26]. In the post-absorptive state, the human body is under fasting 
and the body must rely initially on stored glycogen to supply with glucose to the 
central nervous system and simultaneously regulate plasma glucose concentrations. 
If the fast is prolonged, the glycogen stores end, and the glucose dosage in the liver 
depends only on gluconeogenesis. On the other hand, after an ingested meal, i.e., in 
the postprandial state, absorbed nutrients enter the liver first from hepatic portal 
vein. Consequently, glycogen concentrations in the hepatocytes are restored by 
taking up a portion of the ingested glucose, minimizing the fluctuations of glyce-
mia. In this case, gluconeogenesis is also occurring at a constant rate but the glucose 
output generated from glycogenolysis is suppressed. These result in a net switch 
from hepatic glucose output to hepatic glucose uptake [27].
Hepatic gluconeogenesis occurs by the action of additional groups of 
enzymes that are activated to start synthesizing glucose out of such precursors 
as amino acids and non-hexose carbohydrates such as glutamine, alanine, lactate 
and glycerol. Otherwise, the suppression of the glycogenolysis during the 
post-absorptive period and the activation of the glycogen synthesis during the 
postprandial period are mainly driven by stimulation of insulin secretion and 
suppression of glucagon secretion.
1 Postprandial state is the time frame after a meal or food intake. Postabsorptive state is the period 
following absorption of nutrients from the digestive tract, that is, is the time when enterocytes stop 
providing nutrients to the hepatic portal circulation. Fasting is the willing abstinence or reduction from 
some or all food, drink, or both, for a long period of time (˷ 8 hours).
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In addition to being the primary site of glucose utilization during the post-
prandial period and glucose dosing during the post-absorption period, the liver is 
the primary site of clearance of insulin in the human body [28, 29]. Although the 
kidneys are the main site of extrasplanchnic insulin clearance, with additional con-
tributions resulting from uptake and degradation by peripheral insulin-sensitive 
tissues, i.e., skeletal muscle and adipose tissue, the liver is the main organ respon-
sible for clearance of exogenous and in particular endogenous insulin [30]. Insulin 
clearance from the liver is a dynamic process that can be modified within a few 
days under conditions of changing energy and, in particular, carbohydrate intake 
and before major changes in basal insulin secretion [31]. However, during first-pass 
transit near to 50% of the portal insulin is removed in the liver [32]. Removal of 
insulin from circulation does not imply the immediate destruction of the hormone 
[33]. A significant amount of receptor-bound insulin is released from the cell and 
reenters the circulation [34].
Hepatic glucose uptake is maximally stimulated by conditions that mimic the 
postprandial state, such as portal venous hyperglycemia and hyperinsulinemia 
[35]. Once glucose reaches the hepatocytes, it is phosphorylated to glucose 6-phos-
phate to synthesize glycogen, among other metabolic pathways. The ability of the 
liver to store glycogen is limited, and when glycogen concentrations reach maxi-
mum capacity, the hepatocytes initiate a process known as lipogenesis. Lipogenesis 
is the synthesis of excess glucose into fatty acids [36].
In conclusion, during short periods of fasting, glycogenolysis is the predomi-
nant source of glucose released into the bloodstream. However, during prolonged 
periods of fasting, the glycogen store is gradually depleted and glycogenolysis 
decreases as glycogen stores are depleted. So, gluconeogenesis becomes the pre-
dominant source of glucose for the human body. This unique ability of the human 
liver to store and release glucose is crucial to supporting periods of fasting.
4.3 Kidneys
The kidneys are two bean-shaped organs that are primarily engaged in filtering 
the blood and excreting waste. Filtration is about cleaning the blood to send it back 
into circulation, maintaining an overall fluid balance, creating hormones that help 
make red blood cells, promoting bone health, and regulating blood pressure [37]. 
Recent studies have demonstrated that kidneys also play a central role in glucose 
homeostasis through utilization of glucose, glucose production, and glucose filtration 
and reabsorption via sodium glucose co-transporters (SGLTs) and glucose transport-
ers (GLUT-2). Moreover, the kidneys are an important site of insulin clearance from 
the systemic circulation, removing approximately 50% of peripheral insulin [34].
The kidneys have a super-specialized microscopic structural and functional 
unit called the nephron. Nephrons have the ability to distribute all functions in 
each of their parts. For example, the glomerulus is a network of small blood vessels 
known as capillaries located within Bowman’s capsule. Blood is filtered across the 
glomerular capillaries into Bowman’s space. These capillaries are multiple branches 
of the afferent arteriole but then converge at the efferent arteriole to exit the 
glomerulus and surround the renal tubules, including the proximal convoluted 
tubule, the proximal rectus tubule, the loop of Henle, the distal convoluted tubule, 
and the collecting ducts. Urine continually forms within the tubules to be excreted 
with waste products. Reabsorption, secretion, chemical reactions, and excretion 
also occur within the renal tubules [5].
The release of glucose occurs predominantly in the renal cortex, while the 
utilization of glucose is limited to the renal medulla. For this reason, the kidneys 
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can be considered as two separate organs [38–42]. The renal medulla has an appre-
ciable glucose phosphorylation capacity and, therefore, the ability to accumulate 
glycogen [42]. However, the kidney medulla consumes glucose anaerobically due to 
its low oxygen tension and low levels of oxidative enzymes, limiting the ability to 
produce glucose from glycogen. Consequently, lactate is the main metabolic end 
product of glucose taken up at the renal medulla, unlike carbon dioxide (
2
CO ) and 
water that are the end products of glucose uptake of aerobic energy requirements. 
In contrast, the renal cortex does not have appreciable glycogen stores [43] because 
has little glucose phosphorylation capacity but has a high level of oxidative 
enzymes like 6-phosphatase. Consequently, this part of the kidney does not take 
up and use much glucose, with oxidation of free fatty acids acting as the main 
source of energy [44]. Therefore, it is likely that glucose release by the normal 
kidney is primarily due to gluconeogenesis, that is, the synthesis of glucose-
6-phosphate from non-carbohydrate precursors such as glutamine, lactate, ala-
nine, glycerol, etc. [45], being glutamine the substrate with more specificity in the 
kidney but lactate the most abundant.
In addition, to its function both in the use and in the production of glucose, the 
kidneys contribute to the regulation of glucose in the blood by filtering and reab-
sorbing glucose. The glomeruli filter glucose once it reaches the kidneys, with other 
substances such as precursors and insulin, into the proximal tubules, where all the 
glucose is reabsorbed through the glucose transporting proteins present in the cell 
membranes within the proximal tubules [46], rendering the urine virtually glucose 
free. Before being reabsorbed, gluconeogenesis and glucose uptake occur. Glucose 
production is suppressed by insulin [45] or stimulated by non-carbohydrate 
precursors [41, 47]. An interesting fact is that GLUT-2 glucose transporters are 
independent of insulin and for that reason, the kidneys can continue their physi-
ological functions even in states of insulin deficiency [23].
As before mentioned, gluconeogenesis in the human body is mainly carried out 
by the liver and the kidneys. In the post-absorptive state, both liver and kidneys 
release glucose into the circulation in comparable amounts [48]. However, in the 
postprandial state, although overall endogenous glucose release decreases substan-
tially, renal gluconeogenesis increases by approximately twice liver gluconeogen-
esis. In this sense, the hepatic and renal glucose release into the circulation in the 
post-absorptive state correspond to the 25–30% and 20–25% of total glucose, 
respectively, while in postprandial state, hepatic gluconeogenesis is reduced by  
∼  80% and the release of glucose molecules generated via this pathway decreases 
as these molecules are largely directed into the formation of hepatic glycogen. As a 
consequence of these changes, renal gluconeogenesis increases accounts for ∼  60% 
of postprandial endogenous glucose release [49].
4.4 Gastrointestinal tract
The gastrointestinal (GI) tract is an organ system, consisting of the mouth, 
esophagus, stomach, and intestines, where humans ingest food, digest it to extract 
and absorb energy and nutrients, and expel the remaining waste as feces. However, 
the literature on glucose homeostasis includes the gastrointestinal tract as a com-
plete organ without taking into account the physiological functions and glucose 
consumption of the stomach and small intestine as separate organs involved in 
glucose metabolism.
Meal is ingested through mouth and enters in the stomach to be mixed. The rate 
at which nutrients pass from the stomach to the duodenum, i.e., crossing the 
pyloric valve, is known as the gastric emptying rate and is a key determinant of 
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postprandial glucose flow. In the fed state, glucose homeostasis becomes more 
complex as the gastrointestinal tract becomes a second source of exogenous 
glucose. Marked and rapid changes in glucose flux occur as a result of the consider-
able inflow of meal-derived glucose into the circulation [50]. The delivery of 
nutrients from the gastrointestinal tract occurs through an important rate limiting 
mechanical step in the form of gastric emptying rate: the rate at which the pylorus 
allows small boluses of gastric content to pass into the duodenum for downstream 
absorption. Importantly, neither insulin nor glucagon has direct effects on gastric 
emptying and exogenous glucose diffusion from the gastrointestinal tract [51]. 
However, the influx of glucose is accompanied by secretion of several other regula-
tory hormones of glucose including amylin from β -cells in the pancreas and 
glucose-dependent inhibitory peptide (GIP), glucagon-like peptide-1 (GLP-1), 
and cholecystokinin (CCK) from endocrine cells in the small intestine. Endocrine 
cells in the small intestine collectively influence glucose homeostasis via several 
mechanisms of action including regulation of insulin and glucagon responses, as 
well as the modulation of nutrient passage from the gastrointestinal tract to 
appropriate tissue stores [52–54].
A key contribution of the GI tract on glucose homeostasis is the incretin effect. 
This physiological response came from the observation that an oral glucose load 
results in an increased insulin response compared to the response seen when 
intravenous glucose administration replicates the same changes in plasma glucose 
[55, 56]. In other words, when glucose is ingested orally, an augmented β -cell 
response is observed as a result of a signal passed from the gut. The two hormones 
responsible for this effect are GIP and GLP-1. Both GIP, secreted from entero-
endocrine K-cells in the proximal small bowel, and GLP-1, secreted from enteroen-
docrine L-cells in the distal ileum and colon, have a strong insulinotropic effect 
[57]. Additionally, GLP-1 inhibits postprandial glucagon secretion in a glucose-
dependent manner, slows gastric emptying, and reduces food intake, contributing 
to postprandial glucose regulation [58]. Regarding the role of the stomach in the 
metabolism of glucose, the stomach must consume glucose to generate the energy 
necessary to mechanically carry out the digestion process. Although the consump-
tion of glucose in the stomach is relatively low, it can affect the concentration of 
glucose in the bloodstream.
4.5 Brain
The human brain depends on glucose as its main source of energy; neurons have 
the highest energy demand [59] of all types of cells in the human body, requiring 
continuous delivery of glucose from blood. Glucose metabolism provides the fuel 
for physiological brain function through the generation of ATP, the foundation for 
neuronal and non-neuronal cellular maintenance, as well as the generation of neu-
rotransmittersTherefore, tight regulation of glucose metabolism is critical to brain 
physiology. In this sense, the alteration of glucose metabolism in the brain is the 
basis of several diseases that affect both the brain and the entire organism. Glucose 
is required in the brain to provide the precursors of neurotransmitter synthesis 
and ATP to fuel their actions. Additionally, glucose is important for the brain’s 
energy demands unrelated to signaling. Cellular compartmentalization of glucose 
transport and metabolism are closely related to local regulation of blood flow, and 
glucose-sensing neurons govern the brain–body nutrient axis. Glucose metabolism 
is connected to cell death pathways by the glucose-metabolizing enzymes [60]. 
Thus, disruption glucose delivery pathways and metabolism leads to debilitating 
brain diseases.
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The brain uses about 120 g of glucose per day - 60-70% of the body’s total 
glucose metabolism. The brain has little stored glucose and has no additional 
sources of stored energy. Brain function begins to become seriously affected when 
glucose levels fall below ~ 40 /mg dL. Glucose levels significantly below this can 
lead to permanent damage and death. The brain cannot use fatty acids for energy 
(fatty acids do not cross the blood–brain barrier of the neurons), but ketone bodies 
can enter the brain and be used for energy in hypoglycemic conditions. In this 
sense, the brain can only use glucose, or, under conditions of starvation, ketone 
bodies (acetoacetate and hydroxybutyrate) for energy.
5. Conclusions
Glucose, as the main source of energy for the cells of the human body, is regu-
lated by the joint work of several organs. Each organ involved in this glucose regula-
tory mechanism plays an important role that cannot be disregarded. Metabolic 
disorders such as diabetes mellitus are supposed to only cause an alteration of the 
pancreas, but recent studies indicate that when a condition such as diabetes mellitus 
appears, the rest of the organs are also significantly affected. For this reason, it is 
important to have a healthy lifestyle both to prevent diseases that cause metabolic 
disorders if you do not have them or to have better control of blood glucose levels 
and prevent possible complications that these disorders can cause.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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